Cargando…
Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study
BACKGROUND: Hepatitis C decreases health related quality of life (HRQL) which is further diminished by antiviral therapy. HRQL improves after successful treatment. This trial explores the course of and factors associated with HRQL in patients given individualized or standard treatment based on early...
Autores principales: | Bezemer, Geert, Van Gool, Arthur R, Verheij-Hart, Elke, Hansen, Bettina E, Lurie, Yoav, Esteban, Juan I, Lagging, Martin, Negro, Francesco, Zeuzem, Stefan, Ferrari, Carlo, Pawlotsky, Jean-Michel, Neumann, Avidan U, Schalm, Solko W, de Knegt, Robert J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293759/ https://www.ncbi.nlm.nih.gov/pubmed/22292521 http://dx.doi.org/10.1186/1471-230X-12-11 |
Ejemplares similares
-
Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients: a case control study
por: Bekkering, Frank C, et al.
Publicado: (2001) -
Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms
por: Lagging, Martin, et al.
Publicado: (2011) -
Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection
por: Söderholm, Jonas, et al.
Publicado: (2013) -
Retreatment of hepatitis C non-responsive to Interferon. A placebo controlled randomized trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]
por: Veldt, Bart J, et al.
Publicado: (2003) -
Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study
por: van der Plas, Simone M, et al.
Publicado: (2003)